Journal of Pain and Symptom Management
Volume 36, Issue 4 , Pages 358-366 , October 2008

Fatigue and Its Risk Factors in Cancer Patients Who Seek Emergency Care

  • Carmen P. Escalante, MD

      Affiliations

    • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    • ,
  • Ellen F. Manzullo, MD

      Affiliations

    • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    • ,
  • Tony P. Lam, PhD

      Affiliations

    • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    • ,
  • Joe E. Ensor, PhD

      Affiliations

    • Quantitative Sciences Division, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    • ,
  • Rosalie U. Valdres, MSN

      Affiliations

    • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    • ,
  • Xin Shelley Wang, MD, MPH

      Affiliations

    • Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    • Corresponding Author InformationAddress correspondence to: Xin Shelley Wang, MD, MPH, Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 221, Houston, TX 77030, USA.

,Accepted 1 November 2007.

References 

  1. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park). 2000;14(11A):151–161
  2. National Comprehensive Cancer Network . Cancer-related fatigue and anemia: treatment guidelines for patients. Accessed June 2, 2007. Available at http://www.nccn.org/patients/patient_gls/_english/pdf/NCCN%20Fatigue%20Guidelines.pdf
  3. Cleeland CS, Wang XS. Measuring and understanding fatigue. Oncology. 1999;13(11A):91–97
  4. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;32:40–50
  5. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–753
  6. Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 2002;13(4):589–598
  7. Coackley A, Hutchinson T, Saltmarsh P, et al. Assessment and management of fatigue in patients with advanced cancer: developing guidelines. Int J Palliat Nurs. 2002;8(8):381–388
  8. Knobel H, Loge JH, Nordoy T, et al. High level of fatigue in lymphoma patients treated with high dose therapy. J Pain Symptom Manage. 2000;19(6):446–456
  9. Wang XS, Janjan NA, Guo H, et al. Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer. 2001;92(6 Suppl):1725–1732
  10. Wang XS, Fairclough DL, Liao Z, et al. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol. 2006;24(27):4485–4491
  11. Jacobsen PB, Stein K. Is fatigue a long-term side effect of breast cancer treatment?. Cancer Control. 1999;6(3):256–263
  12. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186–1196
  13. Wang XS, Giralt SA, Mendoza TR, et al. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002;20(5):1319–1328
  14. Ŝĭdák Z. Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc. 1967;62:626–633
  15. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634–1646
  16. Food and Drug Administration . Guidelines for industry (draft). Patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville MD: U.S. Department of Health and Human Services; 2006;
  17. Homsi J, Walsh D, Rivera N, et al. Symptom evaluation in palliative medicine: patient report vs systematic assessment. Support Care Cancer. 2006;14(5):444–453
  18. Miaskowski C. Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:139–143
  19. Schmidt CE, Bestmann B, Kuchler T, et al. Gender differences in quality of life of patients with rectal cancer: a five-year prospective study. World J Surg. 2005;29(12):1630–1641
  20. Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005;103(2):377–382
  21. Hwang SS, Chang VT, Rue M, Kasimis B. Multidimensional independent predictors of cancer-related fatigue. J Pain Symptom Manage. 2003;26(1):604–614
  22. Stone P, Richardson A, Ream E, et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000;11(8):971–975
  23. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97(11):2919–2925
  24. Dantzer R, Bluthe RM, Laye S, et al. Cytokines and sickness behavior. Ann N Y Acad Sci. 1998;840:586–590
  25. Larson SJ, Dunn AJ. Behavioral effects of cytokines. Brain Behav Immun. 2001;15(4):371–387
  26. Lee BN, Dantzer R, Langley KE, et al. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation. 2004;11(5):279–292
  27. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav Immun. 2001;15(1):7–24
  28. McCarthy DO, Kluger MJ, Vander AJ. Suppression of food intake during infection: is interleukin-1 involved?. Am J Clin Nutr. 1985;42(6):1179–1182
  29. Plata-Salaman CR. Brain mechanisms in cytokine-induced anorexia. Psychoneuroendocrinology. 1999;24(1):25–41
  30. Escalante CP. Treatment of cancer-related fatigue: an update. Support Care Cancer. 2003;11(2):79–83
  31. Escalante CP, Manzullo E, Valdres R. A cancer-related fatigue clinic: opportunities and challenges. J Natl Compr Canc Netw. 2003;1(3):333–343

 The authors gratefully acknowledge grant support of this project by Ortho Biotech.Presented in part at the American Society of Clinical Oncology 39th Annual Meeting, June 2003, Chicago, IL, USA.

PII: S0885-3924(08)00146-2

doi: 10.1016/j.jpainsymman.2007.10.018

Journal of Pain and Symptom Management
Volume 36, Issue 4 , Pages 358-366 , October 2008

Article Tools